94 related articles for article (PubMed ID: 21623715)
1. [Clinical- functional assessment of organoprotective efficacy of enalapril and telmisartan in patients with arterial hypertension].
Tatarchenko IP; Pozdniakova NV; Morozova OI; Petrushin IA; Sekerko SA
Kardiologiia; 2011; 51(4):16-21. PubMed ID: 21623715
[TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension and type 2 diabetes mellitus: clinical evaluation of hemodynamic characteristics, possibility of correction].
Tatarchenko IP; Pozdniakova NV; Mordovina AG; Sekerko SA; Morozova OI
Klin Med (Mosk); 2009; 87(10):20-4. PubMed ID: 20017345
[TBL] [Abstract][Full Text] [Related]
3. [The clinical and hemodynamic efficacy of telmisartan and enalapril in the treatment of arterial hypertension in patients with type 2 diabetes mellitus].
Tatarchenko IP; Pozdniakova NV; Mordovina AG; Morozova OI; Zaĭtseva AV
Ter Arkh; 2009; 81(12):11-5. PubMed ID: 20481040
[TBL] [Abstract][Full Text] [Related]
4. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
Smith DH; Matzek KM; Kempthorne-Rawson J
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
Hannedouche T; Chanard J; Baumelou B;
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):246-54. PubMed ID: 11881131
[TBL] [Abstract][Full Text] [Related]
6. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
[TBL] [Abstract][Full Text] [Related]
7. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between changes of endothelial vasodilator function, vascular and cardiac structure and derangements of blood pressure 24-hour profile].
Ripp TM; Mordovin VF; Pekarskiĭ SE
Kardiologiia; 2003; 43(1):36-9. PubMed ID: 12891284
[TBL] [Abstract][Full Text] [Related]
10. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
11. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries.
Erzen B; Gradisek P; Poredos P; Sabovic M
Angiology; 2006; 57(2):187-92. PubMed ID: 16518526
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension].
Gosteva EV; Vasil'eva LV
Kardiologiia; 2015; 55(2):32-6. PubMed ID: 26164986
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
[TBL] [Abstract][Full Text] [Related]
14. ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension.
Amerena J; Pappas S; Ouellet JP; Williams L; O'Shaughnessy D
J Int Med Res; 2002; 30(6):543-52. PubMed ID: 12526280
[TBL] [Abstract][Full Text] [Related]
15. [Chronological structure of arterial pressure in hypertensive patients on enalapril].
Gapon LI; Gubin DG; Semukhin EN; Gubin GD
Klin Med (Mosk); 2001; 79(3):56-9. PubMed ID: 11490421
[TBL] [Abstract][Full Text] [Related]
16. [Effect of telmisartan on the psychological state and quality of life in stable hypertension patients].
Andreeva GF; Gorbunov VM; Aĭvazian TA; Isaĭkina OIu; Voronina VP; Lerman OV
Eksp Klin Farmakol; 2004; 67(6):36-40. PubMed ID: 15707013
[TBL] [Abstract][Full Text] [Related]
17. The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
Pan XD; Zeng ZH; Liang LY; Luo JD; Xiao AY; Lai Q; Wen YH; Lu DF; Wang W; He ZC; He WK
Clin Exp Hypertens; 2011; 33(8):558-64. PubMed ID: 21957976
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension.
Ivanova OV; Fomicheva OA; Sergakova LM; Chernova NA; Rogoza AN; Karpov YA
J Int Med Res; 2005; 33 Suppl 1():21A-29A. PubMed ID: 16222897
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].
Petriĭ VV; Sergushkina NG; Brazhnik VA; Makolkin VI
Ter Arkh; 2008; 80(12):13-6. PubMed ID: 19227900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
